Janus kinase-1 and Janus kinase-2 inhibitors for treating myelofibrosis
about
Evolving Therapeutic Strategies for the Classic Philadelphia-Negative Myeloproliferative NeoplasmsOral ruxolitinib induces hair regrowth in patients with moderate-to-severe alopecia areata.Setting Appropriate Goals for the Next Generation of Clinical Trials in Myelofibrosis.Ruxolitinib in myelofibrosis: to be or not to be an immune disruptor.Fatal ruxolitinib-related JC virus meningitis.Primary myelofibrosis: current therapeutic options.The BCR-ABL1-negative myeloproliferative neoplasms: a review of JAK inhibitors in the therapeutic armamentarium.Benefits and pitfalls of Peg-Interferon-α2a therapy in patients with myeloproliferative neoplasm-associated myelofibrosis, a French Intergroup of Myeloproliferative neoplasms (FIM) study.Philadelphia chromosome-negative classical myeloproliferative neoplasms: revised management recommendations from European LeukemiaNet.Classical Philadelphia-negative myeloproliferative neoplasms: focus on mutations and JAK2 inhibitors
P2860
Q26766319-731761F8-9B72-408F-86D7-61A10C12265CQ34541899-A521E562-C683-41A0-AB52-F0D046FB49B2Q38567540-8F551258-25FA-46F8-ADE8-0963DA4912A1Q38938526-87C40794-B95C-44E6-9943-8A0E8166B3EEQ40044044-EB3B15F4-8BEA-4F54-B90D-A8561B89AE4AQ41186952-3450648F-9895-4708-83BC-7C4A303D05AAQ47581193-7DD7B694-D346-4C0A-A64F-61772F55533BQ50020976-1EAF47B4-C501-440E-A154-1C1F29A177FBQ52668513-6C079051-3FC7-4F88-895D-A4F862AB0E3FQ58801187-4611FDF8-8BA5-46A4-9251-114B17FD7876
P2860
Janus kinase-1 and Janus kinase-2 inhibitors for treating myelofibrosis
description
2015 nî lūn-bûn
@nan
2015 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Janus kinase-1 and Janus kinase-2 inhibitors for treating myelofibrosis
@ast
Janus kinase-1 and Janus kinase-2 inhibitors for treating myelofibrosis
@en
Janus kinase-1 and Janus kinase-2 inhibitors for treating myelofibrosis
@en-gb
Janus kinase-1 and Janus kinase-2 inhibitors for treating myelofibrosis
@nl
type
label
Janus kinase-1 and Janus kinase-2 inhibitors for treating myelofibrosis
@ast
Janus kinase-1 and Janus kinase-2 inhibitors for treating myelofibrosis
@en
Janus kinase-1 and Janus kinase-2 inhibitors for treating myelofibrosis
@en-gb
Janus kinase-1 and Janus kinase-2 inhibitors for treating myelofibrosis
@nl
prefLabel
Janus kinase-1 and Janus kinase-2 inhibitors for treating myelofibrosis
@ast
Janus kinase-1 and Janus kinase-2 inhibitors for treating myelofibrosis
@en
Janus kinase-1 and Janus kinase-2 inhibitors for treating myelofibrosis
@en-gb
Janus kinase-1 and Janus kinase-2 inhibitors for treating myelofibrosis
@nl
P2860
P3181
P1476
Janus kinase-1 and Janus kinase-2 inhibitors for treating myelofibrosis
@en
P2093
Vidhu Anand
P2860
P3181
P356
10.1002/14651858.CD010298.PUB2
P577
2015-04-10T00:00:00Z